Morningstar

PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
Nature

Interpretable machine learning models for survival prediction in prostate cancer bone metastases

Prostate cancer (PCa) is the most prevalent malignancy impacting the male genitourinary system, with approximately 1.6 million new cases and 366,000 deaths reported globally each year 1,2. Factors ...
Nature

Mitigating bias in prostate cancer diagnosis using synthetic data for improved AI driven Gleason grading

Prostate cancer (PCa) is the third most commonly diagnosed cancer globally and a leading cause of cancer-related deaths among males 1,2,3,4,5,6,7. The diagnostic pathway typically starts with ...

Why some men with prostate cancer may soon need only five radiotherapy sessions

For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more ...